Marc Haas
#164,582
Most Influential Person Now
Marc Haas's AcademicInfluence.com Rankings
Marc Haasphilosophy Degrees
Philosophy
#9629
World Rank
#13217
Historical Rank
Logic
#6596
World Rank
#8127
Historical Rank
Marc Haasbiology Degrees
Biology
#13252
World Rank
#16789
Historical Rank
Pathology
#196
World Rank
#327
Historical Rank
Immunology
#909
World Rank
#932
Historical Rank
Download Badge
Philosophy Biology
Why Is Marc Haas Influential?
(Suggest an Edit or Addition)Marc Haas's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Banff 2013 Meeting Report: Inclusion of C4d‐Negative Antibody‐Mediated Rejection and Antibody‐Associated Arterial Lesions (2014) (1195)
- Pathologic classification of diabetic nephropathy. (2010) (1075)
- Banff '05 Meeting Report: Differential Diagnosis of Chronic Allograft Injury and Elimination of Chronic Allograft Nephropathy (‘CAN’) (2007) (1067)
- The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. (2009) (1022)
- The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. (2009) (848)
- Banff ’09 Meeting Report: Antibody Mediated Graft Deterioration and Implementation of Banff Working Groups (2010) (751)
- The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody‐mediated rejection, and prospects for integrative endpoints for next‐generation clinical trials (2018) (709)
- Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions (2008) (663)
- Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group. (2017) (609)
- VEGF inhibition and renal thrombotic microangiopathy. (2008) (570)
- The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology (2016) (509)
- C3 glomerulopathy: consensus report (2013) (473)
- Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases. (1997) (439)
- Changing etiologies of unexplained adult nephrotic syndrome: a comparison of renal biopsy findings from 1976-1979 and 1995-1997. (1997) (414)
- Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices. (2018) (397)
- A 2018 Reference Guide to the Banff Classification of Renal Allograft Pathology (2018) (362)
- Banff 2011 Meeting Report: New Concepts in Antibody‐Mediated Rejection (2012) (360)
- The Use of Antibody to Complement Protein C5 for Salvage Treatment of Severe Antibody‐Mediated Rejection (2008) (292)
- The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell– and antibody‐mediated rejection (2020) (283)
- Plasmapheresis, CMV Hyperimmune Globulin, and Anti‐CD20 Allow ABO‐Incompatible Renal Transplantation Without Splenectomy (2004) (274)
- Evaluation of pathologic criteria for acute renal allograft rejection: reproducibility, sensitivity, and clinical correlation. (1997) (270)
- Transcription factor Nrf2 is protective during ischemic and nephrotoxic acute kidney injury in mice. (2009) (246)
- Etiologies and outcome of acute renal insufficiency in older adults: a renal biopsy study of 259 cases. (2000) (241)
- ABO Incompatible Renal Transplantation: A Paradigm Ready for Broad Implementation (2009) (225)
- Increasing incidence of focal-segmental glomerulosclerosis among adult nephropathies: a 20-year renal biopsy study. (1995) (217)
- Redefining lupus nephritis: clinical implications of pathophysiologic subtypes (2017) (207)
- A Multicenter Study of the Predictive Value of Crescents in IgA Nephropathy. (2017) (199)
- Anti-Angiotensin Type 1 Receptor Antibodies Associated With Antibody Mediated Rejection in Donor HLA Antibody Negative Patients (2010) (191)
- Immune complex deposits in ANCA-associated crescentic glomerulonephritis: a study of 126 cases. (2004) (184)
- Mayo Clinic/Renal Pathology Society Consensus Report on Pathologic Classification, Diagnosis, and Reporting of GN. (2016) (179)
- Specific and durable elimination of antibody to donor HLA antigens in renal-transplant patients (2003) (177)
- Hydroxychloroquine use predicts complete renal remission within 12 months among patients treated with mycophenolate mofetil therapy for membranous lupus nephritis (2006) (173)
- The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults. (2010) (171)
- Pros and cons for C4d as a biomarker. (2012) (169)
- IgA Nephropathy. (2017) (169)
- Monomorphous Angiocentric Glioma: A Distinctive Epileptogenic Neoplasm With Features of Infiltrating Astrocytoma and Ependymoma (2005) (165)
- Sarcoidosis: the nephrologist's perspective. (2006) (145)
- Injury in renal ischemia-reperfusion is independent from immunoglobulins and T lymphocytes. (2002) (144)
- Successful Renal Transplantation across Simultaneous ABO Incompatible and Positive Crossmatch Barriers (2004) (144)
- HIV-associated immune complex glomerulonephritis with "lupus-like" features: a clinicopathologic study of 14 cases. (2005) (144)
- Subclinical Acute Antibody‐Mediated Rejection in Positive Crossmatch Renal Allografts (2007) (144)
- IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation (2017) (143)
- A Phase I/II Trial of the Interleukin-6 Receptor–Specific Humanized Monoclonal (Tocilizumab) + Intravenous Immunoglobulin in Difficult to Desensitize Patients (2015) (140)
- The Utility of Splenectomy as Rescue Treatment for Severe Acute Antibody Mediated Rejection (2007) (126)
- C5a promotes development of experimental lupus nephritis which can be blocked with a specific receptor antagonist (2005) (124)
- A proposal for standardized grading of chronic changes in native kidney biopsy specimens. (2017) (123)
- Recommended Treatment for Antibody-mediated Rejection After Kidney Transplantation: The 2019 Expert Consensus From the Transplantion Society Working Group (2019) (120)
- A Phase I/II Placebo-Controlled Trial of C1-Inhibitor for Prevention of Antibody-Mediated Rejection in HLA Sensitized Patients (2015) (118)
- Transgenic Expression of a Soluble Complement Inhibitor Protects Against Renal Disease and Promotes Survival in MRL/lpr Mice1 (2002) (117)
- HRES-1/Rab4-mediated depletion of Drp1 impairs mitochondrial homeostasis and represents a target for treatment in SLE (2013) (116)
- Early Ultrastructural Changes in Renal Allografts: Correlation With Antibody‐Mediated Rejection and Transplant Glomerulopathy (2011) (115)
- Increased Negative Impact of Donor HLA-Specific Together With Non-HLA–Specific Antibodies on Graft Outcome (2014) (111)
- Complement factor H deficiency accelerates development of lupus nephritis. (2011) (111)
- ABO Antibody Titer and Risk of Antibody‐Mediated Rejection in ABO‐Incompatible Renal Transplantation (2010) (110)
- IgG subclass deposits in glomeruli of lupus and nonlupus membranous nephropathies. (1994) (110)
- Alport syndrome and thin glomerular basement membrane nephropathy: a practical approach to diagnosis. (2009) (109)
- Immune complex glomerulonephritis in C4- and C3-deficient mice. (1998) (109)
- Renal biopsy in lupus patients with low levels of proteinuria. (2007) (107)
- B cell gene signature with massive intrahepatic production of antibodies to hepatitis B core antigen in hepatitis B virus–associated acute liver failure (2010) (105)
- Signaling through Up-Regulated C3a Receptor Is Key to the Development of Experimental Lupus Nephritis1 (2005) (105)
- Banff Histopathological Consensus Criteria for Preimplantation Kidney Biopsies (2016) (104)
- Benefits of Rituximab Combined With Intravenous Immunoglobulin for Desensitization in Kidney Transplant Recipients (2014) (102)
- C4d and C3d Staining in Biopsies of ABO‐ and HLA‐Incompatible Renal Allografts: Correlation with Histologic Findings (2006) (101)
- The relationship of untreated borderline infiltrates by the Banff criteria to acute rejection in renal allograft biopsies. (1999) (100)
- Early clinical experience using donor‐derived cell‐free DNA to detect rejection in kidney transplant recipients (2019) (98)
- Subclinical Rejection in Stable Positive Crossmatch Kidney Transplant Patients: Incidence and Correlations (2009) (98)
- A locus for inherited focal segmental glomerulosclerosis maps to chromosome 19q13. (1998) (97)
- Administration of a soluble recombinant complement C3 inhibitor protects against renal disease in MRL/lpr mice. (2003) (97)
- C4d deposition without rejection correlates with reduced early scarring in ABO-incompatible renal allografts. (2009) (96)
- ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits. (2000) (96)
- Antibody-mediated rejection in renal allografts: lessons from pathology. (2006) (96)
- The Revised (2013) Banff Classification for Antibody‐Mediated Rejection of Renal Allografts: Update, Difficulties, and Future Considerations (2016) (88)
- IgA-dominant postinfectious glomerulonephritis: a report of 13 cases with common ultrastructural features. (2008) (85)
- A reevaluation of routine electron microscopy in the examination of native renal biopsies. (1997) (84)
- Immunotactoid keratopathy: a clinicopathologic case report and a review of reports of corneal involvement in systemic paraproteinemias. (2005) (80)
- Banff 2019 Meeting Report: Molecular diagnostics in solid organ transplantation–Consensus for the Banff Human Organ Transplant (B‐HOT) gene panel and open source multicenter validation (2020) (78)
- Inhibiting the complement system does not reduce injury in renal ischemia reperfusion. (2001) (77)
- Excellent Outcomes after Transplantation of Deceased Donor Kidneys with High Terminal Creatinine and Mild Pathologic Lesions (2005) (74)
- The clinical and pathologic implications of plasmacytic infiltrates in percutaneous renal allograft biopsies. (2001) (73)
- C4d staining of perioperative renal transplant biopsies. (2002) (73)
- Altered vitamin D metabolism in type II diabetic mouse glomeruli may provide protection from diabetic nephropathy. (2006) (72)
- C4d-negative antibody-mediated rejection in renal allografts: evidence for its existence and effect on graft survival. (2011) (69)
- Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodies. (2017) (67)
- Factors Predicting Risk for Antibody-mediated Rejection and Graft Loss in Highly Human Leukocyte Antigen Sensitized Patients Transplanted After Desensitization (2015) (67)
- An updated Banff schema for diagnosis of antibody-mediated rejection in renal allografts (2014) (65)
- Acute renal allograft rejection with intimal arteritis: histologic predictors of response to therapy and graft survival. (2002) (61)
- Complement factor h limits immune complex deposition and prevents inflammation and scarring in glomeruli of mice with chronic serum sickness. (2004) (59)
- Arteriosclerosis in kidneys from healthy live donors: comparison of wedge and needle core perioperative biopsies. (2008) (58)
- A phase I/II, double‐blind, placebo‐controlled study assessing safety and efficacy of C1 esterase inhibitor for prevention of delayed graft function in deceased donor kidney transplant recipients (2018) (57)
- CD20‐Positive Infiltrates in Renal Allograft Biopsies with Acute Cellular Rejection Are Not Associated with Worse Graft Survival (2007) (57)
- Pathology of C4d-negative antibody-mediated rejection in renal allografts (2013) (55)
- Unrestricted C3 activation occurs in Crry-deficient kidneys and rapidly leads to chronic renal failure. (2007) (55)
- Thin glomerular basement membrane nephropathy: incidence in 3471 consecutive renal biopsies examined by electron microscopy. (2009) (55)
- The Revisited Classification of GN in SLE at 10 Years: Time to Re-Evaluate Histopathologic Lesions. (2015) (54)
- Successful retransplantation after renal allograft loss to polyoma virus interstitial nephritis (2002) (52)
- IgA nephropathy in children and adults: comparison of histologic features and clinical outcomes. (2008) (52)
- Mouse podocyte complement factor H: the functional analog to human complement receptor 1. (2007) (50)
- Incidental healed postinfectious glomerulonephritis: a study of 1012 renal biopsy specimens examined by electron microscopy. (2003) (49)
- The XIIIth Banff Conference on Allograft Pathology: The Banff 2015 Heart Meeting Report: Improving Antibody‐Mediated Rejection Diagnostics: Strengths, Unmet Needs, and Future Directions (2016) (49)
- Platelets and capillary injury in acute humoral rejection of renal allografts. (2003) (47)
- The significance of C4d staining with minimal histologic abnormalities (2010) (46)
- Focal and segmental glomerulosclerosis induced in mice lacking decay-accelerating factor in T cells. (2009) (45)
- Glomerular tip lesion in minimal change nephropathy: a study of autopsies before 1950. (2002) (45)
- Granulomatous tubulointerstitial nephritis in the renal allograft. (2000) (44)
- Distinct roles for C3a and C5a in complement-induced tubulointerstitial injury. (2011) (43)
- Oxalate deposits in biopsies from native and transplanted kidneys, and impact on graft function. (2008) (41)
- Histology and immunohistology of IgA nephropathy. (2005) (41)
- Glycogen Pseudoground Glass Change in Hepatocytes (2006) (40)
- Fibrillary/immunotactoid glomerulonephritis in HIV-positive patients: a report of three cases. (2000) (38)
- Drug-induced acute interstitial nephritis in renal allografts: histopathologic features and clinical course in six patients. (1999) (38)
- Donor kidney biopsies: pathology matters, and so does the pathologist. (2014) (38)
- Mycophenolate mofetil as the primary treatment of membranous lupus nephritis with and without concurrent proliferative disease: a retrospective study of 29 cases (2008) (38)
- Isolated endarteritis and kidney transplant survival: a multicenter collaborative study. (2015) (36)
- CTL-Promoting Effects of CD40 Stimulation Outweigh B Cell-Stimulatory Effects Resulting in B Cell Elimination and Disease Improvement in a Murine Model of Lupus1 (2008) (34)
- Histologic classification of glomerular diseases: clinicopathologic correlations, limitations exposed by validation studies, and suggestions for modification. (2014) (34)
- CR1/CR2 Deficiency Alters IgG3 Autoantibody Production and IgA Glomerular Deposition in the MRL/lpr Model of SLE (2004) (33)
- Pathologic features of antibody-mediated rejection in renal allografts: an expanding spectrum (2012) (33)
- Acute renal failure in an HIV-positive 50-year-old man. (2000) (32)
- Histopathologic features of transplant glomerulopathy associated with response to therapy with intravenous immune globulin and rituximab (2014) (32)
- C4d staining of perioperative renal transplant biopsies1 (2002) (30)
- Estimating renal function in lupus nephritis: comparison of the Modification of Diet in Renal Disease and Cockcroft—Gault equations (2007) (29)
- Primary Alveolar Soft Part Sarcoma (ASPS) of the Breast (2005) (28)
- Cocaine use and hypertensive renal changes in HIV-infected individuals. (2007) (28)
- Microangiopathic Lesions in IgA Nephropathy: A Cohort Study. (2019) (28)
- Chronic allograft nephropathy or interstitial fibrosis and tubular atrophy: what is in a name? (2014) (28)
- Tacrolimus therapy for refractory acute renal allograft rejection: definition of the histologic response by protocol biopsies. (1996) (27)
- Fas Expression on Antigen-Specific T Cells Has Costimulatory, Helper, and Down-Regulatory Functions In Vivo for Cytotoxic T Cell Responses but Not for T Cell-Dependent B Cell Responses1 (2008) (27)
- Decay-accelerating factor expression in the rat kidney is restricted to the apical surface of podocytes. (2002) (27)
- Distinct and separable roles of the complement system in factor H-deficient bone marrow chimeric mice with immune complex disease. (2006) (27)
- Consensus Definitions for Glomerular Lesions by Light and Electron Microscopy: Recommendations from a Working Group of the Renal Pathology Society. (2020) (26)
- The relationship between pathologic lesions of active and chronic antibody‐mediated rejection in renal allografts (2018) (26)
- IgA nephropathy histologically resembling focal-segmental glomerulosclerosis: a clinicopathologic study of 18 cases. (1996) (26)
- 30 years of the International Banff Classification for Allograft Pathology: The Past, Present and Future of Kidney Transplant Diagnostics (2021) (25)
- Histologic classification of glomerular diseases: clinicopathologic correlations, limitations exposed by validation studies, and suggestions for modification. (2014) (25)
- VEGF receptor 2 blockade leads to renal cyst formation in mice. (2006) (24)
- Effects of acid aspiration-induced acute lung injury on kidney function. (2008) (24)
- Transplant glomerulopathy: it's not always about chronic rejection. (2011) (24)
- Donor-derived Cell-free DNA and the Prediction of BK Virus-associated Nephropathy (2020) (22)
- Classi fi cation of IgA nephropathy 2016 — the role of crescentic lesions : an update from the IgA Nephropathy Classi fi cation Working Group (2017) (21)
- Donor CD8 T cell activation is critical for greater renal disease severity in female chronic graft-vs.-host mice and is associated with increased splenic ICOS(hi) host CD4 T cells and IL-21 expression. (2010) (20)
- Hematopoietic Stem Cell Transplant-Membranous Nephropathy Is Associated with Protocadherin FAT1 (2022) (19)
- A complement-dependent model of thrombotic thrombocytopenic purpura induced by antibodies reactive with endothelial cells. (2002) (19)
- Evolving criteria for the diagnosis of antibody-mediated rejection in renal allografts (2018) (18)
- Anti-PLA2R-associated membranous nephropathy: a review with emphasis on diagnostic testing methods. (2015) (17)
- Prominent renal expression of a murine leukemia retrovirus in experimental systemic lupus erythematosus. (2002) (17)
- Clinical Relevance of PostTransplant Donor Specific Antibodies (DSAs) in Patients Receiving Desensitization for HLA Incompatible Kidney Transplantation. (2019) (16)
- Isometric Tubular Epithelial Vacuolization in Renal Allograft Biopsy Specimens of Patients Receiving Low-Dose Intravenous Immunoglobulin for a Positive Crossmatch (2004) (15)
- Anti-vascular endothelial growth factor receptor-2 antibody accelerates renal disease in the NZB/W F1 murine systemic lupus erythematosus model. (2005) (15)
- A Validation of the 2018 Revision of International Society of Nephrology/Renal Pathology Society Classification for Lupus Nephritis: A Cohort Study from China (2020) (15)
- Evaluation of Clazakizumab (Anti–Interleukin-6) in Patients With Treatment-Resistant Chronic Active Antibody-Mediated Rejection of Kidney Allografts (2022) (14)
- Loss of CD11b Exacerbates Murine Complement-Mediated Tubulointerstitial Nephritis (2014) (14)
- Collapsing glomerulopathy in systemic lupus erythematosus: an extreme form of lupus podocytopathy? (2012) (13)
- Renal Transplant in Wegener’s Granulomatosis Compared to Microscopic Polyangiitis (2010) (13)
- Complement alternative pathway activation in the autologous phase of nephrotoxic serum nephritis. (2012) (13)
- Morphologic markers of progressive immunoglobulin A nephropathy. (2012) (13)
- Abnormal Immune Complex Processing and Spontaneous Glomerulonephritis in Complement Factor H-Deficient Mice with Human Complement Receptor 1 on Erythrocytes (2010) (12)
- Transplant glomerulopathy: the view from the other side of the basement membrane. (2015) (12)
- In Vivo Maturation of Allo-Specific CD8 CTL and Prevention of Lupus-like Graft-versus-Host Disease Is Critically Dependent on T Cell Signaling through the TNF p75 Receptor But Not the TNF p55 Receptor (2013) (12)
- Collapsing glomerulopathy: many means to a similar end. (2008) (12)
- Rapid accomodation of an A1 renal allograft after preconditioning for ABO-incompatible transplantation. (2009) (11)
- Decay-accelerating factor but not CD59 limits experimental immune-complex glomerulonephritis (2007) (11)
- Deposition and removal of cutaneous beta 2-microglobulin. (1992) (11)
- Monoclonal immunoglobulin G1-kappa fibrillary glomerulonephritis. (1998) (10)
- Bartter syndrome complicated by immune complex nephropathy. Case report and literature review. (2003) (10)
- Clazakizumab for desensitization in highly sensitized patients awaiting transplantation (2021) (10)
- The glomerular tip lesion: what does it really mean? (2005) (9)
- The Role of the Renin-Angiotensin System in Cholesterol and Puromycin Mediated Renal Injury (2002) (9)
- Donor-derived Cell-free DNA Combined With Histology Improves Prediction of Estimated Glomerular Filtration Rate Over Time in Kidney Transplant Recipients Compared With Histology Alone (2020) (9)
- Formalin-fixed paraffin-embedded renal biopsy tissues: an underexploited biospecimen resource for gene expression profiling in IgA nephropathy (2020) (9)
- Hypertension, race, and glomeruli: more than simply a numbers game. (2006) (9)
- Acute renal failure in a 53-year-old woman with Crohn's disease treated with 5-aminosalicylic acid. (2001) (9)
- Postinfectious glomerulonephritis complicating diabetic nephropathy: a frequent association, but how clinically important? (2003) (9)
- RESULTS OF A RANDOMIZED PROSPECTIVE STUDY OF INDUCTION THERAPY WITH DACLIZUMAB VERSUS THYMOGLOBULIN AMONG CROSSMATCH POSITIVE RENAL TRANSPLANT RECIPIENTS: 521 (2008) (8)
- Reversal of accelerated renal allograft rejection with FK 506. (1997) (8)
- Post-Streptococcal Glomerulonephritis (2018) (8)
- Smooth muscle-specific actin levels in the urine of renal transplant recipients: correlation with cyclosporine or tacrolimus nephrotoxicity. (1999) (7)
- Mesoamerican nephropathy: pathology in search of etiology. (2018) (7)
- Chronic active T cell-mediated rejection is variably responsive to immunosuppressive therapy. (2021) (6)
- Overlap of ultrastructural findings in C3 glomerulonephritis and dense deposit disease. (2015) (6)
- Long-term outcome of renal transplantation from older donors. (2006) (6)
- A 49-year-old woman with hematuria, proteinuria, and glomerular immune complex deposits containing IgA and IgG. (2000) (6)
- Clinical and histopathologic features of antibody‐mediated rejection among pediatric renal transplant recipients with preformed vs de novo donor‐specific antibodies (2017) (6)
- Glomerular Disease Pathology in the Era of Proteomics: From Pattern to Pathogenesis. (2017) (5)
- Unrestricted C 3 Activation Occurs in Crry-Deficient Kidneys and Rapidly Leads to Chronic Renal Failure (2007) (5)
- Glomerular diseases associated with hematopoietic neoplasms: an expanding spectrum. (2011) (5)
- Eculizumab as Primary Therapy for Active Antibody-Mediated Rejection of Renal Allografts: A Matter of Timing, Severity, and Donor-Specific Antibodies. (2019) (5)
- Standardized reporting of monoclonal immunoglobulin-associated renal diseases: recommendations from a Mayo Clinic/Renal Pathology Society Working Group. (2020) (5)
- Successful transplantation across HLA and ABO sensitization (2002) (5)
- Molecular diagnostics in renal allograft biopsy interpretation: potential and pitfalls. (2014) (5)
- Paraprotein-associated thrombotic microangiopathy: expanding the spectrum of renal disease related to plasma cell dyscrasias. (2017) (4)
- An Assessment of the Value of Donor-derived Cell-free DNA Surveillance in Patients With Preserved Kidney Allograft Function (2022) (4)
- Use of a donor‐derived cell‐free DNA assay to monitor treatment response in pediatric renal transplant recipients with allograft rejection (2022) (4)
- Crescents and IgA Nephropathy: A Delicate Marriage (2022) (4)
- ANTI-CD20 RESCUE THERAPY FOR ACUTE ANTIBODY-MEDIATED REJECTION IN KIDNEY TRANSPLANT RECIPIENTS (2004) (4)
- Mesangial cell complement receptor 1‐related protein y limits complement‐dependent neutrophil accumulation in immune complex glomerulonephritis (2009) (3)
- Immunoglobulin G/albumin staining in tubular protein reabsorption droplets in minimal change disease and focal segmental glomerulosclerosis. (2020) (3)
- Risk factors for the development of antibody‐mediated rejection in highly sensitized pediatric kidney transplant recipients (2017) (3)
- Long term tolerability and clinical outcomes associated with tocilizumab in the treatment of refractory antibody mediated rejection (AMR) in pediatric renal transplant recipients (2022) (3)
- Does the definition of chronic active T cell–mediated rejection need revisiting? (2020) (3)
- Membranous Nephropathy in Syphilis is Associated with Neuron-Derived Neurotrophic Factor (2023) (2)
- 463 Anti -Angiotensin Type 1 Receptor (AT1R) Antibodies Together with Anti-HLA Donor Specific Antibodies (HLA-DSA) Identify Patients at Risk for Immune Complication in Heart Transplant (2012) (2)
- Collagen type III glomerulopathy. (2018) (2)
- Pulmonary embolization of bovine collagen. (2009) (2)
- Bartter syndrome complicated by immune complex nephropathy (2003) (2)
- Role of protocol biopsies in the treatment of refractory renal allograft rejection with FK 506. (1996) (2)
- Simultaneous liver-kidney transplantation: shifting renal allograft gene expression from inflammation toward preservation. (2017) (2)
- Uncovering the etiology of CINAC, a complex and mysterious renal syndrome: the invaluable role of histopathology and electron microscopy. (2020) (2)
- Study 1: characterization of acute rejection episodes after pre-emptive plasmapheresis and cytomegalovirus hyperimmune globulin to abrogate a positive crossmatch and allow live donor renal transplantation (2003) (2)
- Unmasking a unique glomerular lesion. (2014) (2)
- Emerging Concepts and Controversies in Renal Pathology: C4d-Negative and Arterial Lesions as Manifestations of Antibody-Mediated Transplant Rejection. (2014) (1)
- The pathologist's view. (2020) (1)
- An automated histological classification system for precision diagnostics of kidney allografts. (2023) (1)
- Comments on Famulski and Halloran AJT i‐IFTA letter (2018) (1)
- Incidences of membranous nephropathy versus focal segmental glomerulosclerosis: increase in the former or decline in the latter? (2013) (1)
- CJASN Glomerular Disease Education Series: IgA Nephropathy (2017) (1)
- Temporal Trends in the Epidemiology of Biopsy-Proven Glomerular Diseases: An Alarming Increase in Diabetic Glomerulosclerosis. (2017) (1)
- C3 Glomerulopathy: A Review with Emphasis on Ultrastructural Features (2022) (1)
- Severe crescentic glomerulonephritis with occasional immune-complex deposits: one disease or two? (1998) (1)
- IgA Nephropathy: Does Histologic Grading Really Matter? (2008) (1)
- Emerging Concepts and Controversies in Renal (2014) (1)
- Transplant Glomerulopathy With Glomerular C3 Deposits: Why the Worse Outcome? (2019) (1)
- Immunoglobulin A-dominant post-infectious glomerulonephritis (2018) (0)
- Critical role of C5aR signals in bone marrow-derived cells in an accelerated lupus nephritis model (2012) (0)
- Improvement in a Murine Model of Lupus Resulting in B Cell Elimination and Disease Outweigh B Cell-Stimulatory Effects CTL-Promoting Effects of CD 40 Stimulation (2008) (0)
- P050 : CORRELATION OF THE PRESENCE OF COMPLEMENT BINDING DE NOVO DSA AND PATHOLOGY DEFINED ANTIBODY MEDIATED REJECTION (pAMR) IN HEART RECIPIENTS (2014) (0)
- Glomerulonephritis associated with endocarditis, deep-seated infections, and shunt nephritis (2018) (0)
- Update on scoring and providing evidence basis for assessing pathology in lupus nephritis. (2023) (0)
- Specific phenotypes induced by deficiency of complement receptors type 1 and type 2 in murine SLE (2002) (0)
- Quantitative scoring of progression in transplant glomerulopathy using digital pathology may be superior to Banff cg scoring. (2022) (0)
- Long-term outcome of renal transplantation from older donors [8] (2006) (0)
- ELIMINATION OF SPLENECTOMY AND ANTI-CD20 THERAPY DOES NOT RESULT IN INCREASED CHRONIC ALLOGRAFT NEPHROPATHY: A SINGLE CENTER EXPERIENCE IN ABO-INCOMPATIBLE RENAL TRANSPLANTATION: 430 (2008) (0)
- Unmasking a unique glomerular (2014) (0)
- Cell-Mediated Glomerulonephritis Without Immune Complexes in Native Kidney Biopsies: A Report of 7 Cases. (2021) (0)
- Progressive postinfectious glomerulonephritis with multiple tubuloreticular inclusions in an HIV-negative patient. (1997) (0)
- CLINICOPATHOLOGIC FEATURES OF UNTREATED BORDERLINE CHANGES BY THE BANFF CRITERIA IN RENAL ALLOGRAFT BIOPSIES. (1998) (0)
- Incidental discovery of a renal cell carcinoma on native kidney biopsy. (2010) (0)
- PLASMAPHERESIS/CMVIG RESCUE THERAPY FOR ACUTE ANTIBODY-MEDIATED REJECTION IN KIDNEY TRANSPLANT RECIPIENTS (2004) (0)
- Does the Presence of Complement Binding De Novo DSA Distinguish Different Pathology Defined Rejection Patterns in Heart Transplant Recipients (2014) (0)
- RESULTS Upregulation of Nrf 2 target genes in the kidneys of mice subjected to ischemia – reperfusion Using (2009) (0)
- Histopathologic Correlates of Progression of Transplant Glomerulopathy (TG).: Abstract# C1748 (2014) (0)
- Anti-Vascular Endothelial Growth Factor Therapy and Renal Thrombotic Microangiopathy (2017) (0)
- Receptor TNF p 75 Receptor But Not the TNF p 55 Dependent on T Cell Signaling through the Graft-versus-Host Disease Is Critically CTL and Prevention of Lupus-like In Vivo Maturation of Allo-Specific CD 8 (2013) (0)
- Towards harmony in defining and reporting glomerular diseases on kidney biopsy (2021) (0)
- Experimental Lupus Nephritis Receptor Is Key to the Development of Signaling through Up-Regulated C3a (2005) (0)
- Both donor specific and non-donor specific HLA antibodies reduced in recipients post simultaneous liver/kidney transplant. (2022) (0)
- Pre‐transplant angiotensin II receptor type I antibodies in pediatric renal transplant recipients: An observational cohort study (2022) (0)
- Transplantation Pathology SECOND EDITION P. Ruiz (Editor) Cambridge, UK: Cambridge University Press, 2018, 386 pages. (2018) (0)
- Accelerated development of lupus nephritis in MRL-lpr mice lacking complement factor H (2010) (0)
- Donor CD8 T cell activation is critical for sex based differences in lupus-like disease in DBA-into-F1 mice. (93.31) (2010) (0)
- Complement factor H (CfH) on rodent podocytes is the functional counterpart to human podocyte complement receptor 1 (CR1) (2007) (0)
- A Banff-based histologic chronicity index is associated with graft loss in patients with a kidney transplant and antibody-mediated rejection. (2022) (0)
- Poster Session 2—Liver/Intestine Posters (2019) (0)
- THE UTILITY OF PROTOCOL BIOPSIES IN INCOMPATIBLE KIDNEY TRANSPLANT RECIPIENTS. (2006) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Marc Haas?
Marc Haas is affiliated with the following schools:
